We demonstrated that elevated CHCHD4 orchestrates mitochondrial oxidative phosphorylation and antagonizes aberrant proliferation and migration of PASMCs, thereby disturbing hypoxic PAH. This evidence concerns the gene CHCHD4 and pulmonary arterial hypertension.